Director Deals - Shield Therapeutics PLC (STX)

Writer,

Archived article

Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.

Timothy Watts, Chief Executive Officer, bought 100,000 shares in the company on the 19th January 2021 at a price of £0.60. The Director now holds 748,700 shares.

Director deals data provided by www.sharesmagazine.co.uk